Clinical Trial Update: A Clinical Comparison of FDA-Cleared Photobiomodulation Devices for the Treatment of Alopecia [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update comparing FDA-cleared photobiomodulation devices for alopecia, focusing on safety and preliminary efficacy signals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia

Drugs mentioned

• Multiple FDA-cleared photobiomodulation devices

Snippet

Sponsor: University of Minnesota | Conditions: Alopecia | EARLY_Phase 1 | Status: COMPLETED